McMillan Shakespeare (ASX:MMS) Asset Impairment Charge: A$0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:MMS McMillan Shakespeare Ltd ASX:MMS
75 GF Score
Price A$20.00
GF Value A$19.91
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is McMillan Shakespeare Asset Impairment Charge?

McMillan Shakespeare ASX:MMS -0.74% 75 Asset Impairment Charge is A$0.0 Mil as of Jun. 2026. GuruFocus rates ASX:MMS with a GF Score™ of 75/100 and a GF Value™ of A$19.91 (Fairly Valued). The stock has 11 warning signs investors should review.

McMillan Shakespeare's Asset Impairment Charge for the six months ended in Jun. 2026 was A$0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.0 Mil.

McMillan Shakespeare Asset Impairment Charge Related Terms

McMillan Shakespeare Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for McMillan Shakespeare's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McMillan Shakespeare Asset Impairment Charge Chart

McMillan Shakespeare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

McMillan Shakespeare Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:MMS
75GF Score
McMillan Shakespeare Ltd ASX:MMS
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

McMillan Shakespeare Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

What does a Asset Impairment Charge of A$0.0 Mil mean?
McMillan Shakespeare (ASX:MMS) has a Asset Impairment Charge of A$0.0 Mil as of Jun. 2026.
Is McMillan Shakespeare's Asset Impairment Charge too high?
McMillan Shakespeare's current Asset Impairment Charge is A$0.0 Mil. Overall, McMillan Shakespeare has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McMillan Shakespeare's Asset Impairment Charge compare to RHI and KFY?
McMillan Shakespeare's Asset Impairment Charge of A$0.0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Business Services company?
A good Asset Impairment Charge depends on the Business Services industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. McMillan Shakespeare's current Asset Impairment Charge is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McMillan Shakespeare stock overvalued right now?
Based on GuruFocus' analysis, McMillan Shakespeare (ASX:MMS) is currently considered Fairly Valued. The stock's GF Value™ is A$19.91, compared to a current price of A$20.00 — trading 0.5% above its estimated fair value. The current Asset Impairment Charge is A$0.0 Mil. McMillan Shakespeare's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For McMillan Shakespeare (ASX:MMS), the current Asset Impairment Charge is A$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McMillan Shakespeare (ASX:MMS) Overvalued in 2026?

Based on GuruFocus' analysis, McMillan Shakespeare stock appears to be overvalued. The current stock price of A$20.00 is trading 0.5% above its estimated GF Value™ of A$19.91. GuruFocus considers McMillan Shakespeare to be Fairly Valued.

Key valuation signals for ASX:MMS:

  • Asset Impairment Charge: A$0.0 Mil
  • GF Value™: A$19.91 vs. price of A$20.00 (0.5% above fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the ASX:MMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McMillan Shakespeare Business Description

Other Exchanges NMN:Germany
Address 360 Elizabeth Street, Level 21, The Tower, Melbourne Central, Melbourne, VIC, AUS, 3000
McMillan Shakespeare is a provider of salary packaging, novated leasing, disability plan management and support co-ordination, and fleet management services. It actively works to cross-sell its products to clients, for example, selling its salary packaging services to its fleet management customers in Australia and New Zealand. McMillan dominates Australia's salary packaging market together with Smartgroup (also covered by Morningstar), and is also a large provider of novated leasing services by volumes—together with Smartgroup and SG Fleet. The group has three operating segments: group remuneration services, asset management services, and plan and support services. Most of the group's revenue is generated from the group remuneration services segment.
75GF Score

Get the complete analysis for ASX:MMS

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$20.00
Price
A$19.91
GF Value